Muhammad Murtaza Shafqat, Ali Raza Naqvi, Amir Shafique, Rashid Ali Khosa, Shabeer Ahmed, Hazar Khan Bugti. Ryzodeg (Insulin Degludec/Aspart) for Type 2 Diabetes in Pakistan: A 12-Week Study on Glycemic Control and Safety Outcomes. Pakistan Journal of Medical & Health Sciences [Internet]. 2022 Sep. 30 [cited 2025 Dec. 5];16(09):1003. Available from: https://www.pjmhsonline.com/index.php/pjmhs/article/view/6542